UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
In a recent study, researchers at University of California San Diego School of Medicine found a seventh component of wisdom: spirituality.
The National Academy of Medicine (NAM) has announced that University of California San Diego Professor Susan Ackerman, a pioneer in the study of homeostasis in developing and aging neurons, has been elected to membership in the prestigious organization.
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.
Two research teams at UC San Diego School of Medicine sought to understand sedentary lifestyles, with one study finding that even light physical activity, including just standing, can benefit health, and the other that Americans are sitting too much.
UC San Diego School of Medicine researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.
A team from the San Diego Supercomputer Center at UC San Diego contributed to a study led by the Vanderbilt Vaccine Center on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens, including Coronavirus SARS-CoV-2.
J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.
Two University of California San Diego researchers have received prestigious awards through the 2020 National Institutes of Health (NIH) High-Risk, High-Reward Research Program.